Drugmaker Johnson & Johnson has issued a recall for lots of the antipsychotic medication Risperdal and its generic equivalent risperidone because of a bad odor reported in some of the tablets. The odor may be due to a chemical preservative called TBA that is used to treat the wooden pallets on which the drugs are shipped. About 16,000 bottles of the 3 mg Risperdal tablets that were shipped between last August and February are affected in the recall. Also included are about 24,000 bottles of...
Read moreIn this post I will share some of the research about an anti-psychotic medication called Risperdal. I will also share our personal... Read more »
Risperdal - generic risperidone - is an antipsychotic medication. It's approved as a treatment for schizophrenia (adults and adolescents... Read more »
We have been talking a lot about medications here on ADHD Central lately. Part of the reason for this is that so many of you write in with... Read more »
Not a week goes by without a patient inquiring about the use of complementary and alternative medicine (CAM) in treating rheumatoid... Read more »
Therapy for multiple sclerosis doesn't only mean medications made by pharmaceutical companies, but also physical and occupational therapy,... Read more »
Bipolar patients who experience frequent relapses may be helped by adding risperidone long-lasting injections (RLAI) to their current medication... Read more »
These are adult asthmatics who sometimes have mild asthma symptoms, and when they do they take a puff or two or three or four of their quick-relief... Read more »
Mark James Borigini, MD, graduated from Hahnemann University (now Drexel University) School of Medicine in 1988 and completed a residency in Internal... Read more »
Most people don't think twice about getting their prescriptions filled. But according to experts, building a relationship with your family pharmacy,... Read more »
Alternative medicine products and procedures such as chiropractic care, herbal supplements, acupuncture, and meditation cost Americans $33.9 billion... Read more »